These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26471204)

  • 21. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.
    Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC;
    Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outpatient parenteral antimicrobial therapy today.
    Paladino JA; Poretz D
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S198-208. PubMed ID: 20731577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful outpatient parenteral antibiotic therapy delivery via telemedicine.
    Tan SJ; Ingram PR; Rothnie AJ; Whitmore TJ; Robinson JO; Hatch JB; Italiano CM; Heath CH
    J Antimicrob Chemother; 2017 Oct; 72(10):2898-2901. PubMed ID: 29091189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
    Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
    Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
    Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
    JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Palms DL; Jacob JT
    Clin Infect Dis; 2020 Jan; 70(1):67-74. PubMed ID: 30810165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Kritsotakis EI; Johnston P; Kenny T; Ntziora F; Cartwright K
    Clin Microbiol Infect; 2019 Jul; 25(7):905.e1-905.e7. PubMed ID: 30502491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical predictors of outcome in patients with infective endocarditis receiving outpatient parenteral antibiotic therapy (OPAT).
    Durojaiye OC; Morgan R; Chelaghma N; Kritsotakis EI
    J Infect; 2021 Dec; 83(6):644-649. PubMed ID: 34614400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy.
    Sharma R; Loomis W; Brown RB
    Am J Med Sci; 2005 Aug; 330(2):60-4. PubMed ID: 16103785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
    Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
    J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.
    Suleyman G; Kenney R; Zervos MJ; Weinmann A
    J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.
    Martone WJ; Lindfield KC; Katz DE
    Int J Clin Pract; 2008 Aug; 62(8):1183-7. PubMed ID: 18705821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.
    Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK
    J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients.
    Beieler AM; Dellit TH; Chan JD; Dhanireddy S; Enzian LK; Stone TJ; Dwyer-O'Connor E; Lynch JB
    J Hosp Med; 2016 Aug; 11(8):531-5. PubMed ID: 27120700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Assessment of an Outpatient Antimicrobial Therapy Program in a Rural Medical Center : A Retrospective Chart Review.
    Burkett MS; Macci Bires A; Cline TW; Knight A
    Crit Care Nurs Q; 2018; 41(2):109-120. PubMed ID: 29494367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
    Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
    Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
    Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.
    Psaltikidis EM; Silva END; Bustorff-Silva JM; Moretti ML; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):355-375. PubMed ID: 28776441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.